SIV replication in human cells

Frontiers in Microbiology

Volumn 3, Issue APR, 2012, Pages

  Sakuma, Ryuta ^a   Takeuchi, Hiroaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

APOBEC3G; Cyclophilin A; Cyclophilin B; HIV 1; SIV; TRIM5

Indexed keywords

EID: 84875643571     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00162     Document Type: Article

References (120)

1. Ackerson, B., Rey, O., Canon, J., and Krogstad, P. (1998). Cells with high cyclophilin A content support replication of human immunodeficiency virus type 1 Gag mutants with decreased ability to incorporate cyclophilin A. J. Virol. 72, 303-308.
2. Akari, H., Sakuragi, J., Takebe, Y., Tomonaga, K., Kawamura, M., Fuka-sawa, M., Miura, T., Shinjo, T., and Hayami, M. (1992). Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells. Arch. Virol. 123, 157-167.
3. Berthoux, L., Sebastian, S., Sokolskaja, E., and Luban, J. (2004). Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA. J. Virol. 78, 11739-11750.
4. Besnier, C., Takeuchi, Y., and Towers, G. (2002). Restriction of lentivirus in monkeys. Proc. Natl. Acad. Sci. U.S.A. 99, 11920-11925.
5. Bishop, K. N., Holmes, R. K., Sheehy, A. M., Davidson, N. O., Cho, S. J., and Malim, M. H. (2004a). Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 14, 1392-1396.
6. Bishop, K. N., Holmes, R. K., Sheehy, A. M., and Malim, M. H. (2004b). APOBEC-mediated editing of viral RNA. Science 305, 645.
7. Blanc, D., Patience, C., Schulz, T. E, Weiss, R., and Spire, B. (1993). Transcomplementation of VIF-HIV-1 mutants in CEM cells suggests that VIF affects late steps of the viral life cycle. Virology 193, 186-192.
8. Bogerd, H. P., Doehle, B. P., Wie-gand, H. L., and Cullen, B. R. (2004). A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc. Natl. Acad. Sci. U.S.A. 101, 3770-3774.
9. Borman, A. M., Quillent, C., Charneau, P., Dauguet, C., and Clavel, F. (1995). Human immunodeficiency virus type 1 Vif-mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. J. Virol. 69, 2058-2067.
10. Bosco, D. A., Eisenmesser, E. Z., Pochap-sky, S., Sundquist, W. I., and Kern, D. (2002). Catalysis of cis/trans iso-merization in native HIV-1 capsid by human cyclophilin A. Proc. Natl. Acad. Sci. U.S.A. 99, 5247-5252.
11. Braaten, D., Aberham, C., Franke, E K., Yin, L., Phares, W., and Luban, J. (1996a). Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional tar get of cyclophilin A. J. Virol. 70, 5170-5176.
12. Braaten, D., Franke, E. K., and Luban, J. (1996b). Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 70, 3551-3560.
13. Braaten, D., Franke, E. K., and Luban, J. (1996c). Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses. J. Virol. 70, 4220-4227.
14. Braaten, D., and Luban, J. (2001). Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. EMBO J. 20, 1300-1309.
15. Brennan, G., Kozyrev, Y., and Hu, S. L. (2008). TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis. Proc. Natl. Acad. Sci. U.S.A. 105, 3569-3574.
16. Bukovsky, A. A., Weimann, A., Accola, M. A., and Gottlinger, H. G. (1997). Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence. Proc. Natl. Acad. Sci. U.S.A. 94, 10943-10948.
17. Cagliani, R., Fumagalli, M., Biasin, M., Piacentini, L., Riva, S., Pozzoli, U., Bonaglia, M. C., Bresolin, N., Clerici, M., and Sironi, M. (2010). Long-term balancing selection maintains trans-specific polymorphisms in the human TRIM5 gene. Hum. Genet. 128, 577-588.
18. Campbell, E. M., Perez, O., Anderson, J. L., and Hope, T. J. (2008). Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha. J. Cell Biol. 180, 549-561.
19. Chen, Z., Telfier, P., Gettie, A., Reed, P., Zhang, L., Ho, D. D., and Marx, P.A. (1996). Genetic characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop. J. Virol. 70, 3617-3627.
20. Colgan, J., Yuan, H. E., Franke, E. K., and Luban, J. (1996). Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization. J. Virol. 70, 4299-4310.
21. Cowan, S., Hatziioannou, T., Cunningham, T., Muesing, M. A., Gottlinger, H. G., and Bieniasz, P. D. (2002). Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl. Acad. Sci. U.S.A. 99, 11914-11919.
22. Cullen, B. R. (2006). Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J. Virol. 80, 1067-1076.
23. Dang, Y., Siew, L. M., Wang, X., Han, Y., Lampen, R., and Zheng, Y H. (2008). Human cytidine deaminase APOBEC3H restricts HIV-1 replication. J. Biol. Chem. 283, 11606-11614.
24. Dang, Y., Wang, X., Esselman, W. J., and Zheng, Y. H. (2006). Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family. J. Virol. 80, 10522-10533.
25. Diaz-Griffero, F., Li, X., Javan-bakht, H., Song, B., Welikala, S., Stremlau, M., and Sodroski, J. (2006). Rapid turnover and polyu-biquitylation of the retroviral restriction factor TRIM5. Virology 349, 300-315.
26. Dietrich, E. A., Jones-Engel, L., and Hu, S. L. (2010). Evolution of the antiretroviral restriction factor TRIMCyp in Old World primates. PLoS ONE 5, e14019. doi: 10.1371/journal.pone.0014019
27. Doehle, B. P., Schafer, A., and Cullen, B. R. (2005). Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif. Virology 339, 281-288.
28. Dorfman, T., and Gottlinger, H. G. (1996). The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811. J. Virol. 70, 5751-5757.
29. Fan, L., and Peden, K. (1992). Cell-free transmission of Vif mutants of HIV-1. Virology 190, 19-29.
30. Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T., and Schmid, F. X. (1989). Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 337, 476-478.
31. Fisher, A. G., Ensoli, B., Ivanoff, L., Chamberlain, M., Petteway, S., Rat-ner, L., Gallo, R. C., and Wong-Staal, F. (1987). The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237, 888-893.
32. Franke, E. K., and Luban, J. (1996). Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. Virology 222, 279-282.
33. Franke, E. K., Yuan, H. E., and Luban, J. (1994). Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372, 359-362.
34. Gabuzda, D. H., Lawrence, K., Langhoff, E., Terwilliger, E., Dorfman, T., Haseltine, W. A., and Sodroski, J. (1992). Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J. Virol. 66, 6489-6495.
35. Gamble, T. R., Vajdos, F. F., Yoo, S., Worthylake, D. K., Houseweart, M., Sundquist, W. I., and Hill, C. P. (1996). Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87, 1285-1294.
36. Ganser-Pornillos, B. K., Chandrasekaran, V., Pornillos, O., Sodroski, J. G., Sundquist, W. I., and Yeager, M. (2011). Hexagonal assembly of a restricting TRIM5alpha protein. Proc. Natl. Acad. Sci. U.S.A. 108, 534-539.
37. Gao, F., Bailes, E., Robertson, D. L., Chen, Y., Rodenburg, C. M., Michael, S. F., Cummins, L. B., Arthur, L. O., Peeters, M., Shaw, G. M., Sharp, P. M., and Hahn, B. H. (1999). Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397, 436-441.
38. Gautsch, J. W., Elder, J. H., Schindler, J., Jensen, F. C., andLerner, R.A. (1978). Structural markers on core protein p30 of murine leukemia virus: functional correlation with Fv-1 tropism. Proc. Natl. Acad. Sci. U.S.A. 75, 4170-4174.
39. Goff, S. P. (2004). Genetic control of retrovirus susceptibility in mammalian cells. Annu. Rev. Genet. 38, 61-85.
40. Guo, F., Cen, S., Niu, M., Saadatmand, J., and Kleiman, L. (2006). Inhibition of formula-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication. J. Virol. 80, 11710-11722.
41. Guo, F., Cen, S., Niu, M., Yang, Y., Gorelick, R. J., and Kleiman, L. (2007). The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNA3Lys annealing to viral RNA. J. Virol. 81, 11322-11331.
42. Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., and Malim, M. H. (2003). DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803-809.
43. Harris, R. S., and Liddament, M. T. (2004). Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol. 4, 868-877.
44. Hatziioannou, T., Cowan, S., Goff, S. P., Bieniasz, P. D., and Towers, G. J. (2003). Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBOJ. 22, 385-394.
45. Hatziioannou, T., Cowan, S., von Schwedler, U. K., Sundquist, W. I., and Bieniasz, P. D. (2004a). Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. J. Virol. 78, 6005-6012.
46. Hatziioannou, T., Perez-Caballero, D., Yang, A., Cowan, S., and Bieniasz, P. D. (2004b). Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc. Natl. Acad. Sci. U.S.A. 101, 10774-10779.
47. Hatziioannou, T., Perez-Caballero, D., Cowan, S., and Bieniasz, P. D. (2005). Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells. J. Virol. 79, 176-183.
48. Hatziioannou, T., Princiotta, M., Piatak, M. Jr., Yuan, F., Zhang, F., Lifson, J. D., and Bieniasz, P. D. (2006). Generation of simian-tropic HIV-1 by restriction factor evasion. Science 314, 95.
49. Himathongkham, S., and Luciw, P. A. (1996). Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells. Virology 219, 485-488.
50. Hirsch, V M., Olmsted, R. A., Murphey-Corb, M., Purcell, R. H., and Johnson, P. R. (1989). An African primate lentivirus (SIVsm) closely related to HIV-2. Nature 339, 389-392.
51. Hofmann, W., Schubert, D., Labonte, J., Munson, L., Gibson, S., Scammell, J., Ferrigno, P., and Sodroski, J. (1999). Species-specific, postentry barriers to primate immunodeficiency virus infection. J. Virol. 73, 10020-10028.
52. Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., and Skowronski, J. (2011). Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474, 658-661.
53. Ikeda, Y., Ylinen, L. M., Kahar-Bador, M., and Towers, G. J. (2004). Influence of gag on human immunodeficiency virus type 1 species-specific tropism.J. Virol. 78, 11816-11822.
54. Javanbakht, H., Diaz-Griffero, F., Yuan, W., Yeung, D. F., Li, X., Song, B., and Sodroski, J. (2007). The ability of multimerized cyclophilin A to restrict retrovirus infection. Virology 367, 19-29.
55. Kamada, K., Igarashi, T., Martin, M. A., Khamsri, B., Hatcho, K., Yamashita, T., Fujita, M., Uchiyama, T., and Adachi, A. (2006). Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc. Natl. Acad. Sci. U.S.A. 103, 16959-16964.
56. Kar, A. K., Diaz-Griffero, F., Li, Y., Li, X., and Sodroski, J. (2008). Biochemical and biophysical characterization of a chimeric TRIM21-TRIM5alpha protein.J. Virol. 82, 11669-11681.
57. Keckesova, Z., Ylinen, L. M., and Towers, G. J. (2004). The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc. Natl. Acad. Sci. U.S.A. 101, 10780-10785.
58. Kootstra, N. A., Munk, C., Tonnu, N., Landau, N. R., and Verma, I. M. (2003). Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc. Natl. Acad. Sci. U.S.A. 100, 1298-1303.
59. Kozak, C. A., and Chakraborti, A. (1996). Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance. Virology 225, 300-305.
60. Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Segeral, E., Yatim, A., Emil-iani, S., Schwartz, O., and Benki-rane, M. (2011). SAMHD1 is the dendritic-and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654-657.
61. Lecossier, D., Bouchonnet, F., Clavel, F., and Hance, A. J. (2003). Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300, 1112.
62. Le Tortorec, A., and Neil, S. J. (2009). Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J Virol. 83, 11966-11978.
63. Li, X., and Sodroski, J. (2008). The TRIM5alpha B-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higher-order self-association. J. Virol. 82, 11495-11502.
64. Li, X. Y., Guo, F., Zhang, L., Kleiman, L., and Cen, S. (2007). APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription. J Biol. Chem. 282, 32065-32074.
65. Liddament, M. T., Brown, W. L., Schumacher, A. J., and Harris, R. S. (2004). APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr. Biol. 14, 1385-1391.
66. Luban, J., Bossolt, K. L., Franke, E. K., Kalpana, G. V., and Goff, S. P. (1993). Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73, 1067-1078.
67. Luo, K., Wang, T., Liu, B., Tian, C., Xiao, Z., Kappes, J., and Yu, X. E (2007). Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation. J Virol. 81, 7238-7248.
68. Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., and Trono, D. (2003). Broad antiretro-viral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103.
69. Mangeat, B., Turelli, P., Liao, S., and Trono, D. (2004). A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action. J. Biol. Chem. 279, 14481-14483.
70. Mariani, R., Chen, D., Schrofelbauer, B., Navarro, F., Konig, R., Bollman, B., Munk, C., Nymark-Mcmahon, H., and Landau, N. R. (2003). Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114, 21-31.
71. Mbisa, J. L., Barr, R., Thomas, J. A., Vandegraaff, N., Dorweiler, I. J., Svarovskaia, E. S., Brown, W. L., Mansky, L. M., Gorelick, R. J., Harris, R. S., Engelman, A., and Pathak, V K. (2007). Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration. J. Virol. 81, 7099-7110.
72. Mische, C. C., Javanbakht, H., Song, B., Diaz-Griffero, F., Stremlau, M., Strack, B., Si, Z., and Sodroski, J. (2005). Retroviral restriction factor TRIM5alpha is a trimer. J. Virol. 79, 14446-14450.
73. Munk, C., Brandt, S. M., Lucero, G., and Landau, N. R. (2002). A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc. Natl. Acad. Sci. U.S.A. 99, 13843-13848.
74. Neil, S. J., Zang, T., and Bieniasz, P. D. (2008). Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425-430.
75. Newman, R. M., Hall, L., Connole, M., Chen, G. L., Sato, S., Yuste, E., Diehl, W., Hunter, E., Kaur, A., Miller, G. M., and Johnson, W.E. (2006). Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha. Proc. Natl. Acad. Sci. U.S.A. 103, 19134-19139.
76. Nisole, S., Stoye, J. P., and Saib, A. (2005). TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 3, 799-808.
77. Ott, D. E., Coren, L. V., Johnson, D. G., Sowder II, R. C., Arthur, L. O., and Henderson, L. E. (1995). Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain. AIDS Res. Hum. Retroviruses 11, 1003-1006.
78. Owens, C. M., Song, B., Perron, M. J., Yang, P. C., Stremlau, M., and Sodroski, J. (2004). Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 cap-sid. J. Virol. 78, 5423-5437.
79. Owens, C. M., Yang, P. C., Gottlinger, H., and Sodroski, J. (2003). Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells. J. Virol. 77, 726-731.
80. Pacheco, B., Finzi, A., Mcgee-Estrada, K., and Sodroski, J. (2010). Species-specific inhibition of foamy viruses from South American monkeys by New World Monkey TRIM5α proteins. J. Virol. 84, 4095-4099.
81. Perron, M. J., Stremlau, M., Song, B., Ulm, W., Mulligan, R. C., and Sodroski, J. (2004). TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc. Natl. Acad. Sci. U.S.A. 101, 11827-11832.
82. Rein, A., Kashmiri, S. V., Bassin, R. H., Gerwin, B. L., and Duran-Troise, G. (1976). Phenotypic mixing between N-and B-tropic murine leukemia viruses: infectious particles with dual sensitivity to Fv-1 restriction. Cell 7, 373-379.
83. Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Rig-anelli, D., Zanaria, E., Messali, S., Cainarca, S., Guffanti, A., Minucci, S., Pelicci, P. G., and Ballabio, A. (2001). The tripartite motif family identifies cell compartments. EMBO J.20, 2140-2151.
84. Rose, K. M., Marin, M., Kozak, S. L., and Kabat, D. (2005). Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G. AIDS Res. Hum. Retroviruses 21, 611-619.
85. Sakai, H., Shibata, R., Sakuragi, J., Sakuragi, S., Kawamura, M., and Adachi, A. (1993). Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J. Virol. 67, 1663-1666.
86. Sakuma, R., Noser, J. A., Ohmine, S., and Ikeda, Y. (2007). Rhesus monkey TRIM5alpha restricts HIV-1 production through rapid degradation of viral Gag polyproteins. Nat. Med. 13, 631-635.
87. Sayah, D. M., Sokolskaja, E., Berthoux, L., and Luban, J. (2004). Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430, 569-573.
88. Schrofelbauer, B., Chen, D., and Landau, N. R. (2004). A single amino acid of APOBEC3G controls its species-specific interaction with virion infec-tivity factor (Vif). Proc. Natl. Acad. Sci. U.S.A. 101, 3927-3932.
89. Shibata, R., Kawamura, M., Sakai, H., Hayami, M., Ishimoto, A., and Adachi, A. (1991). Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells.J. Virol. 65, 3514-3520.
90. Shibata, R., Sakai, H., Kawamura, M., Tokunaga, K., andAdachi, A. (1995). Early replication block of human immunodeficiency virus type 1 in monkey cells. J. Gen. Virol. 76(Pt 11), 2723-2730.
91. Si, Z., Vandegraaff, N., O'huigin, C., Song, B., Yuan, W., Xu, C., Perron, M., Li, X., Marasco, W. A., Engel-man, A., Dean, M., and Sodroski, J. (2006). Evolution of a cytoplas-mic tripartite motif (TRIM) protein in cows that restricts retroviral infection. Proc. Natl. Acad. Sci. U.S.A. 103, 7454-7459.
92. Simon, J. H., Miller, D. L., Fouch-ier, R. A., Soares, M. A., Peden, K. W., and Malim, M. H. (1998). The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission. EMBO J. 17, 1259-1267.
93. Sokolskaja, E., Sayah, D. M., and Luban, J. (2004). Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.J. Virol. 78, 12800-12808.
94. Song, B., Javanbakht, H., Perron, M., Park, D. H., Stremlau, M., and Sodroski, J. (2005). Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. J. Virol. 79, 3930-3937.
95. Strebel, K., Daugherty, D., Clouse, K., Cohen, D., Folks, T., and Martin, M. A. (1987). The HIV A' (sor) gene product is essential for virus infectivity. Nature 328, 728-730.
96. Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., and Sodroski, J. (2004). The cytoplas-mic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427, 848-853.
97. Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D. J., Sundquist, W. I., and Sodroski, J. (2006). Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. U.S.A. 103, 5514-5519.
98. Takahashi, N., Hayano, T., and Suzuki, M. (1989). Peptidyl-prolyl cistrans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 337, 473-475.
99. Takeuchi, H., Buckler-White, A., Goila-Gaur, R., Miyagi, E., Khan, M. A., Opi, S., Kao, S., Sokolskaja, E., Pertel, T., Luban, J., and Strebel, K. (2007). Vif counteracts a cyclophilin A-imposed inhibition of simian immunodeficiency viruses in human cells. J. Virol. 81, 8080-8090.
100. Takeuchi, H., Ishii, H., Kuwano, T., Inagaki, N., Akari, H., and Matano, T. (2012). Host cell species-specific effect of cyclosporine A on simian immunodeficiency virus replication. Retrovirology 9, 3.
101. Takeuchi, H., Kao, S., Miyagi, E., Khan, M. A., Buckler-White, A., Plishka, R., and Strebel, K. (2005). Production of infectious SIVagm from human cells requires functional inactivation but not viral exclusion of human APOBEC3G. J. Biol. Chem. 280, 375-382.
102. Thali, M., Bukovsky, A., Kondo, E., Rosenwirth, B., Walsh, C. T., Sodroski, J., and Gottlinger, H. G. (1994). Functional association of cyclophilin A with HIV-1 virions. Nature 372, 363-365.
103. Towers, G., Bock, M., Martin, S., Takeuchi, Y., Stoye, J. P., and Danos, O. (2000). A conserved mechanism of retrovirus restriction in mammals. Proc. Natl. Acad. Sci. U.S.A. 97, 12295-12299.
104. Towers, G. J., Hatziioannou, T., Cowan, S., Goff, S. P., Luban, J., and Bieniasz, P. D. (2003). Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat. Med. 9, 1138-1143.
105. van Manen, D., Rits, M. A., Beugeling, C., Van Dort, K., Schuitemaker, H., andKootstra, N.A. (2008). The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection. PLoS Pathog. 4, e18. doi: 10.1371/jour-nal.ppat.0040018.
106. von Schwedler, U., Song, J., Aiken, C., and Trono, D. (1993). Vif iscrucialfor human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67, 4945-4955.
107. Wiegand, H. L., Doehle, B. P., Bogerd, H. P., and Cullen, B. R. (2004). A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBOJ. 23, 2451-2458.
108. Wilson, S. J., Webb, B. L., Ylinen, L. M., Verschoor, E., Heeney, J. L., and Towers, G. J. (2008). Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc. Natl. Acad. Sci. U.S.A. 105, 3557-3562.
109. Wu, X., Anderson, J. L., Campbell, E. M., Joseph, A. M., and Hope, T. J. (2006). Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. Proc. Natl. Acad. Sci. U.S.A. 103, 7465-7470.
110. Xu, H., Svarovskaia, E. S., Barr, R., Zhang, Y., Khan, M. A., Strebel, K., and Pathak, V K. (2004). A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Proc. Natl. Acad. Sci. U.S.A. 101, 5652-5657.
111. Yap, M. W., Nisole, S., Lynch, C., and Stoye, J. P. (2004). TRIM5alpha protein restricts both HIV-1 and murine leukemia virus. Proc. Natl. Acad. Sci. U.S.A. 101, 10786-10791.
112. Ylinen, L. M., Keckesova, Z., Wilson, S. J., Ranasinghe, S., and Towers, G. J. (2005). Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles. J. Virol. 79, 11580-11587.
113. Yu, Q., Chen, D., Konig, R., Mariani, R., Unutmaz, D., and Landau, N. R. (2004a). APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J Biol. Chem. 279, 53379-53386.
114. Yu, Q., Konig, R., Pillai, S., Chiles, K., Kearney, M., Palmer, S., Rich-man, D., Coffin, J. M., and Landau, N. R. (2004b). Single-strand specificity of APOBEC3G accounts for minusstrand deamination of the HIV genome. Nat. Struct. Mol. Biol. 11, 435-442.
115. Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., and Yu, X. F. (2003). Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302, 1056-1060.
116. Zhang, F., Perez-Caballero, D., Hatziioannou, T., and Bieniasz, P. D. (2008). No effect of endogenous TRIM5alpha on HIV-1 production. Nat. Med. 14, 235-236; author reply 236-238.
117. Zhang, F., Wilson, S. J., Landford, W. C., Virgen, B., Gregory, D., Johnson, M. C., Munch, J., Kirchhoff, F., Bieniasz, P. D., and Hatziioannou, T. (2009). Nef proteins from simian immunodeficiency viruses are teth-erin antagonists. Cell Host Microbe 6, 54-67.
118. Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., and Gao, L. (2003). The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424, 94-98.
119. Zhao, Y., Chen, Y., Schutkowski, M., Fischer, G., and Ke, H. (1997). Cyclophilin A complexed with a fragment of HIV-1 gag protein: insights into HIV-1 infectious activity. Structure5, 139-146.
120. Zheng, Y. H., Irwin, D., Kurosu, T., Tokunaga, K., Sata, T., and Peter-lin, B. M. (2004). Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J. Virol. 78, 6073-6076.